Business Context and Reporting Period
This Form 8-K is a current report filed by AntriaBio, Inc. (not Rezolute, Inc.) on September 25, 2013. The filing addresses a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a personnel change and contains no financial data.
Material Changes
Departure of Director: On September 25, 2013, Nickolay Kukekov resigned from his position as a member of the Board of Directors. The Company stated that the resignation was not the result of any disagreements regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the standard disclosure regarding the director's resignation.
Investor Verification Checklist
- Verify the identity of the registrant (AntriaBio, Inc.) versus the requested company name (Rezolute, Inc.).
- Confirm the effective date of the director's resignation (September 25, 2013).
- Check subsequent filings to determine if a replacement director was appointed.
- Review the Company's most recent 10-K or 10-Q for actual financial performance metrics, as this 8-K does not contain them.